News
US President Donald Trump urged 17 major pharmaceutical companies to implement "Most-Favored-Nation (MFN)" pricing on ...
Merck will reduce its workforce by approximately 6,000 employees in “some areas of our global workforce,” the New Jersey ...
WASHINGTON (Reuters) -U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, ...
Dragged down by losses for shares of UnitedHealth and Merck, the Dow Jones Industrial Average is falling Thursday afternoon.
President Trump urges top pharmaceutical firms to lower U.S. drug prices under his most-favored-nation drug pricing policy ...
Instil's licensed PD-L1xVEGF bispecific shows promise in China, instilling hope for upcoming US test
A PD-L1xVEGF bispecific antibody from China’s ImmuneOnco Biopharmaceuticals has shown early promise in shrinking lung tumors, ...
Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo ...
Drug maker Merck announced Tuesday it will embark on an initiative to cut $3 billion in costs 2027, including an undisclosed ...
With Bitcoin reaching record levels this year, Strategy's stock has benefited from the growing popularity of the top ...
Merck & Co., Inc. (NYSE: MRK) is one of the most undervalued blue chip stocks to buy according to hedge funds. On July 21, ...
Employees of the technology transfer center ANAXAM and researchers from the Paul Scherrer Institute PSI used the unique ...
Vinay Prasad, a top FDA official, suddenly departed after a series of controversial decisions about a Duchenne gene therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results